116 related articles for article (PubMed ID: 15261892)
1. Plasminogen activator inhibitor 1, fibrin, and the vascular response to injury.
Fay WP
Trends Cardiovasc Med; 2004 Jul; 14(5):196-202. PubMed ID: 15261892
[TBL] [Abstract][Full Text] [Related]
2. A DNA enzyme against plasminogen activator inhibitor- type 1 (PAI-1) limits neointima formation after angioplasty in an obese diabetic rodent model.
Witkowski P; Seki T; Xiang G; Martens T; Sondermeijer H; See F; Bhagat G; Schuster M; Hardy MA; Itescu S
J Cardiovasc Pharmacol; 2007 Dec; 50(6):633-40. PubMed ID: 18091579
[TBL] [Abstract][Full Text] [Related]
3. [Expression of urokinase plasminogen activator, its receptor and plasminogen activator inhibitor type 1 in different types of atherosclerotic lesion in human aorta].
Solomatina MA; Plekhanova OS; Il'inskaia OP; Kalinina NI; Mikhaĭlova EV; Tsokolaeva ZI; Tararak EM; Naumov VG; Parfenova EV
Tsitologiia; 2004; 46(4):352-60. PubMed ID: 15346794
[TBL] [Abstract][Full Text] [Related]
4. uPAR-uPA-PAI-1 interactions and signaling: a vascular biologist's view.
Binder BR; Mihaly J; Prager GW
Thromb Haemost; 2007 Mar; 97(3):336-42. PubMed ID: 17334498
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of plasminogen activator inhibitor-1 with fibrin deposition in a murine model of aging, "Klotho" mouse.
Takeshita K; Yamamoto K; Ito M; Kondo T; Matsushita T; Hirai M; Kojima T; Nishimura M; Nabeshima Y; Loskutoff DJ; Saito H; Murohara T
Semin Thromb Hemost; 2002 Dec; 28(6):545-54. PubMed ID: 12536348
[TBL] [Abstract][Full Text] [Related]
6. Plasminogen activator inhibitor-1 in acute hyperoxic mouse lung injury.
Barazzone C; Belin D; Piguet PF; Vassalli JD; Sappino AP
J Clin Invest; 1996 Dec; 98(12):2666-73. PubMed ID: 8981909
[TBL] [Abstract][Full Text] [Related]
7. Antiproliferative agents alter vascular plasminogen activator inhibitor-1 expression: a potential prothrombotic mechanism of drug-eluting stents.
Muldowney JA; Stringham JR; Levy SE; Gleaves LA; Eren M; Piana RN; Vaughan DE
Arterioscler Thromb Vasc Biol; 2007 Feb; 27(2):400-6. PubMed ID: 17158352
[TBL] [Abstract][Full Text] [Related]
8. Rac-1 promotes pulmonary artery smooth muscle cell proliferation by upregulation of plasminogen activator inhibitor-1: role of NFkappaB-dependent hypoxia-inducible factor-1alpha transcription.
Diebold I; Djordjevic T; Hess J; Görlach A
Thromb Haemost; 2008 Dec; 100(6):1021-8. PubMed ID: 19132225
[TBL] [Abstract][Full Text] [Related]
9. Vascular functions of the plasminogen activation system.
Fay WP; Garg N; Sunkar M
Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1231-7. PubMed ID: 17379840
[TBL] [Abstract][Full Text] [Related]
10. The 'PAI-1 paradox' in vascular remodeling.
Diebold I; Kraicun D; Bonello S; Görlach A
Thromb Haemost; 2008 Dec; 100(6):984-91. PubMed ID: 19132221
[TBL] [Abstract][Full Text] [Related]
11. Highly stable plasminogen activator inhibitor type one (VLHL PAI-1) protects fibrin clots from tissue plasminogen activator-mediated fibrinolysis.
Jankun J; Aleem AM; Selman SH; Skrzypczak-Jankun E; Lysiak-Szydlowska W; Grafos N; Fryer HJ; Greenfield RS
Int J Mol Med; 2007 Nov; 20(5):683-7. PubMed ID: 17912461
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of TGF-beta1-induced intimal growth: plasminogen-independent activities of plasminogen activator inhibitor-1 and heterogeneous origin of intimal cells.
Otsuka G; Stempien-Otero A; Frutkin AD; Dichek DA
Circ Res; 2007 May; 100(9):1300-7. PubMed ID: 17431190
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of plasminogen activator inhibitor-1 expression by siRNA in rat hepatic stellate cells.
Hu PF; Zhu YW; Zhong W; Chen YX; Lin Y; Zhang X; Yin C; Yue HY; Xie WF
J Gastroenterol Hepatol; 2008 Dec; 23(12):1917-25. PubMed ID: 18761555
[TBL] [Abstract][Full Text] [Related]
14. C-type natriuretic peptide (CNP) suppresses plasminogen activator inhibitor-1 (PAI-1) in vivo.
Kairuz EM; Barber MN; Anderson CR; Kanagasundaram M; Drummond GR; Woods RL
Cardiovasc Res; 2005 Jun; 66(3):574-82. PubMed ID: 15914122
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional profiling after bile duct ligation identifies PAI-1 as a contributor to cholestatic injury in mice.
Wang H; Vohra BP; Zhang Y; Heuckeroth RO
Hepatology; 2005 Nov; 42(5):1099-108. PubMed ID: 16250054
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor beta 1 induces neointima formation through plasminogen activator inhibitor-1-dependent pathways.
Otsuka G; Agah R; Frutkin AD; Wight TN; Dichek DA
Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):737-43. PubMed ID: 16373605
[TBL] [Abstract][Full Text] [Related]
17. [From fibrinogen to fibrin and its dissolution].
Juhan-Vague I; Hans M
Bull Acad Natl Med; 2003; 187(1):69-82; discussion 83-4. PubMed ID: 14556455
[TBL] [Abstract][Full Text] [Related]
18. Plasminogen activator inhibitor-1 from bone marrow-derived cells suppresses neointimal formation after vascular injury in mice.
Schäfer K; Schroeter MR; Dellas C; Puls M; Nitsche M; Weiss E; Hasenfuss G; Konstantinides SV
Arterioscler Thromb Vasc Biol; 2006 Jun; 26(6):1254-9. PubMed ID: 16514083
[TBL] [Abstract][Full Text] [Related]
19. Plasminogen activator inhibitor-1 and diabetic nephropathy.
Lee HB; Ha H
Nephrology (Carlton); 2005 Oct; 10 Suppl():S11-3. PubMed ID: 16174279
[TBL] [Abstract][Full Text] [Related]
20. Intramural plasminogen activator inhibitor type-1 and coronary atherosclerosis.
Sobel BE; Taatjes DJ; Schneider DJ
Arterioscler Thromb Vasc Biol; 2003 Nov; 23(11):1979-89. PubMed ID: 12920048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
